WuXi Biologics (Cayman) Inc. (HKG:2269)

WuXi Biologics Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 18, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	130,957	72,100	124,993	252,882	390,943	419,914
Market Cap Growth	83.17%	-42.32%	-50.57%	-35.32%	-6.90%	228.81%
Enterprise Value	127,319	71,052	122,776	247,673	380,146	418,224
Last Close Price	31.92	17.56	29.60	59.85	92.55	102.80
PE Ratio	29.47	20.19	33.37	50.61	93.99	209.36
Forward PE	23.19	17.09	22.71	37.41	77.91	168.15
PS Ratio	5.96	3.63	6.66	14.65	30.95	63.00
PB Ratio	2.44	1.49	2.58	6.18	9.74	16.92
P/TBV Ratio	2.78	1.70	2.96	6.79	10.56	17.69
P/FCF Ratio	67.93	52.62	182.37	-	-	-
P/OCF Ratio	20.89	12.99	24.31	40.37	92.82	187.95
PEG Ratio	1.21	1.99	1.39	1.02	1.99	3.92
EV/Sales Ratio	5.79	3.58	6.54	14.35	30.10	62.75
EV/EBITDA Ratio	16.70	11.42	22.61	43.22	85.50	198.82
EV/EBIT Ratio	21.16	14.56	28.34	50.36	97.69	234.41
EV/FCF Ratio	66.05	51.85	179.13	-	-	-
Debt / Equity Ratio	0.10	0.11	0.10	0.12	0.13	0.16
Debt / EBITDA Ratio	0.73	0.82	0.89	0.86	1.18	1.85
Debt / FCF Ratio	2.90	3.84	7.33	-	-	-
Asset Turnover	0.34	0.33	0.32	0.33	0.28	0.24
Inventory Turnover	6.36	6.71	5.04	4.31	3.94	4.15
Quick Ratio	2.40	1.98	2.35	1.56	1.85	2.49
Current Ratio	2.88	2.73	2.78	1.98	2.37	3.16
Return on Equity (ROE)	10.51%	8.82%	8.90%	13.20%	13.09%	10.02%
Return on Assets (ROA)	5.89%	5.05%	4.63%	5.81%	5.43%	4.03%
Return on Capital (ROIC)	6.64%	5.79%	5.51%	7.00%	6.47%	4.78%
Return on Capital Employed (ROCE)	10.60%	9.50%	8.00%	10.80%	8.90%	6.10%
Earnings Yield	3.51%	4.95%	3.00%	1.98%	1.06%	0.48%
FCF Yield	1.47%	1.90%	0.55%	-0.15%	-0.97%	-1.17%
Buyback Yield / Dilution	2.55%	2.80%	0.62%	1.04%	-5.05%	-5.30%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.